Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Purine nucleoside phosphorylase (PNP) deficiency is a disorder of purine metabolism characterized by progressive immunodeficiency leading to recurrent and opportunistic infections, autoimmunity and malignancy as well as neurologic manifestations.
Features include always present findings: Decreased urinary urate, Ataxia, Pure red cell aplasia, and Decreased total lymphocyte count and others. 38 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 12 | Recurrent lower respiratory tract infections, Autoimmune hemolytic anemia, Recurrent opportunistic infections |
PNP function has not been fully characterized.
Purine nucleoside phosphorylase deficiency is caused by mutations in the PNP gene on chromosome 14.
Genetic testing for PNP is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for purine nucleoside phosphorylase deficiency has been reported in the published literature.
Phenotype severity distribution: 9 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
2 clinical trials registered, 2 recruiting. Interventions under study include other interventions and biologic therapy. Research is primarily sponsored by academic and government institutions.
27 publications have been identified in PubMed for purine nucleoside phosphorylase deficiency. Research spans Basic Science / Preclinical (37%), Review / Meta-Analysis (15%), and Case Report / Case Series (11%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 10 |
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 6:56 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Brain and nerves |
7 |
Ataxia, Intellectual disability, Spastic diplegia |
Kidneys and urinary system | 4 | Decreased urinary urate, Recurrent urinary tract infections, Elevated urinary inosine level |
Lungs and breathing | 3 | Recurrent lower respiratory tract infections, Pneumonia, Recurrent upper respiratory tract infections |
Muscles | 3 | Low muscle tone (hypotonia), Generalized hypotonia, Delayed gross motor development |
Lab test results | 2 | Increased circulating inosine concentration, Increased circulating guanosine concentration |
Growth and development | 1 | Failure to thrive |
Digestive system | 1 | Enlarged spleen (splenomegaly) |
Ears | 1 | Otitis media |
Research summaries | 4 | 15% |
Patient case studies | 3 | 11% |
Disease patterns and progression | 3 | 11% |
Other research | 2 | 7% |
Testing and diagnosis research | 2 | 7% |
Clinical study results | 2 | 7% |
New treatment approaches | 1 | 4% |
Herrmann US (2026). [PMID: 40983033](https://pubmed.ncbi.nlm.nih.gov/40983033/). *Blood*. [Clinical Trial Publication]
Grunebaum E (2026). [PMID: 41505148](https://pubmed.ncbi.nlm.nih.gov/41505148/). *Blood*. [Other]
Ahuja M (2026). [PMID: 41627577](https://pubmed.ncbi.nlm.nih.gov/41627577/). *J Clin Immunol*. [Other]
Hara H (2026). [PMID: 41199135](https://pubmed.ncbi.nlm.nih.gov/41199135/). *Am J Surg Pathol*. [Gene Therapy / Novel Therapeutics]
Rodon J (2026). [PMID: 41512197](https://pubmed.ncbi.nlm.nih.gov/41512197/). *Cancer Res*. [Review / Meta-Analysis]
Zhang S (2025). [PMID: 40062378](https://pubmed.ncbi.nlm.nih.gov/40062378/). *Mol Cancer Ther*. [Basic Science / Preclinical]
Bettiol A (2025). [PMID: 40981309](https://pubmed.ncbi.nlm.nih.gov/40981309/). *Int J Neonatal Screen*. [Case Report / Case Series]
Ikushima H (2025). [PMID: 40138743](https://pubmed.ncbi.nlm.nih.gov/40138743/). *ESMO Open*. [Basic Science / Preclinical]
Shi Z (2025). [PMID: 41247922](https://pubmed.ncbi.nlm.nih.gov/41247922/). *J Med Chem*. [Epidemiology / Natural History]
Pettus LH (2025). [PMID: 40146197](https://pubmed.ncbi.nlm.nih.gov/40146197/). *J Med Chem*. [Clinical Trial Publication]